Key attributes

What the platforms bring to a program

Patented platforms

Two patented expression routes: bacterial secretion and mammalian expression.

Extracellular secretion

Suitable recombinant proteins and peptides are produced directly into the culture medium.

Complex biologics

CHO-based expression for glycosylated biologics that require mammalian folding and processing.

Simplified recovery

For compatible molecules, less reliance on cell lysis, inclusion-body isolation and refolding.

Scalable development

Mammalian bioreactors at 5 L and microbial fermenters to 1,000 L, with 5,000 L planned.

Proven in our products

Used to design, develop and manufacture every product in the SysGene portfolio.

Evidence

The evidence behind our platforms

Both platforms have been established at laboratory scale. Platform performance, scale-up requirements and product quality are evaluated separately for each molecule.

Proven in our own portfolio

Every product in the SysGene portfolio has been designed, developed and manufactured using SysGene’s patented bacterial secretion and mammalian expression platforms, the same platforms offered for development, licensing and technology-transfer programs.

Explore the products→

How we present technical evidence

We present technical information according to the strength and source of the supporting evidence, enabling partners to distinguish confirmed specifications from representative results, development targets and external benchmarks.

Validated specification

A confirmed product specification supported by an approved test method and controlled documentation.

SUPPORTED BY TECHNICAL DOCUMENTATION

Representative result

A result observed under defined study or program conditions.

PRESENTED WITH THE RELEVANT METHODS, CONDITIONS AND LIMITATIONS

Development target

A performance objective under evaluation that has not yet been established as a product specification.

CLEARLY IDENTIFIED AS A DEVELOPMENT TARGET

External benchmark

Published third-party data used to provide relevant technical or market context.

REFERENCED TO THE ORIGINAL SOURCE
Platform results are molecule- and process-specific. Reported development outcomes do not guarantee equivalent performance for other products, scales or manufacturing configurations.

Assess platform fit for your molecule

Share the molecular format and quality target and we will assess the appropriate route.

Evaluate a Molecule